Clinical Trials Directory

Trials / Conditions / Cancer-associated Thrombosis

Cancer-associated Thrombosis

8 registered clinical trials studyying Cancer-associated Thrombosis — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingDevelopment of a Risk Stratification Score for Recurrent Venous Thromboembolism and Treatment-related Clinical
NCT06894576
Ottawa Hospital Research Institute—
RecruitingThe Gynecological Cancer Associated Thrombosis (GynCAT) Study
NCT06284343
Fondazione Policlinico Universitario Agostino Gemelli IRCCS—
RecruitingSTrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis
NCT05255003
Tzu-Fei WangPhase 4
CompletedAPI-CAT STUDY for APIxaban Cancer Associated Thrombosis
NCT03692065
Assistance Publique - Hôpitaux de ParisPhase 3
UnknownA Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Di
NCT03139487
Asan Medical CenterPhase 2
CompletedRivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer
NCT01989845
Seoul National University HospitalPhase 4
CompletedA New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient
NCT03114618
Andres muñoz—
CompletedEfficacy and Safety of Extended Anticoagulant Therapy in Cancer Associated Thrombosis in Thai Population
NCT07388056
Thammasat University—